サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631528

合成低分子API市場規模、シェア、動向分析レポート：メーカー別、用途別、地域別、セグメント予測、2025年～2030年

Synthetic Small Molecule API Market Size, Share & Trends Analysis Report By Manufacturer (In-house, Outsourced), By Application (Oncology, Pulmonology, CNS, Endocrinology), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
合成低分子API市場規模、シェア、動向分析レポート：メーカー別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月17日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

合成低分子API市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の合成低分子API市場規模は、2025～2030年にかけて5.6%のCAGRを記録し、2030年までに2,574億米ドルに達すると推定されています。

この背景には、医薬品や低分子ベースの新薬に対する世界の需要の増加があります。さらに、低分子APIは剤形間の汎用性があり、精製が容易であるため、受け入れられやすく、需要が増加しています。

製薬産業では合成医薬品の優位性が高まっており、低分子原薬のような生産用原料の必要性が高まると予想されます。さらに、既存製品の強化に関連する技術の進歩は、低分子治療に新たな機会を提供すると予想されます。例えば、Evonikは2022年3月、経口低分子の溶解性を高める新しいEUDRATECSoluFlow技術を発表しました。

この市場を牽引しているのは、様々な地域における原薬生産に対する政府の積極的な支援であり、特にアジアでは、原薬メーカーの大半が合成低分子原薬の生産を原薬の供給に依存しています。原薬製造のアウトソーシングへの注目も高まっています。例えば、2020年4月、COVID-19を管理するために、波長製薬は呼吸器重症患者の管理に必要な特定の医薬品の主要原薬の供給を拡大し、API CDMOサービスを開始しました。中国、インド、東南アジアなどの新興市場は大きな成長機会です。

アジアのメーカーは、大量生産が可能なあまり複雑でない分子に重点を置いているため、新しく複雑な技術への投資は比較的少ないです。そのため、欧州や北米など他の先進地域のメーカーにとっては、高収率・低コスト技術への投資が競合圧力を回避するための選択肢となります。

同市場で事業を展開する主要企業は、強力なAPI製品の生産に向けた提携に注力しています。例えば、2021年8月、Almac Sciencesは、高活性かつ選択的な低分子TRPV1拮抗薬であるAPI XEN-D0501の製造に関してPila Pharmaと契約を締結しました。さらに、CDMOは合成医薬品の需要の高まりに対応するため、能力を拡大することで絶えず進化しています。例えば、AGC Inc.は2022年4月にスペインの合成医薬品生産施設を7,500m2拡大すると発表しており、この地域での合成低分子原薬の需要拡大が期待されています。

合成低分子API市場レポートハイライト

  • 市場全体の成長は、原料需要の増加に伴う医薬品生産の増加に起因します。
  • API市場は、合成低分子医薬品原薬の大量生産におけるCDMOへの選好の高まりという重要な変化を目の当たりにしています。
  • メーカー別では、中堅・中小企業が商業生産をアウトソーシングに依存していることから、アウトソーシング部門が予測期間中に最も速いCAGRを示すと予想されます。
  • 用途別では、慢性疾患であることと世界的に有病率が高いことから、2024年には心血管疾患セグメントが21.7%の市場シェアを占め、市場を独占しました。
  • 北米は、主要企業の存在と、同地域のAPI製造能力強化に対する政府からの支援の高まりにより、2024年の市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 合成小分子API市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 合成小分子API市場：メーカービジネス分析

  • メーカー市場シェア、2024年と2030年
  • メーカーセグメントダッシュボード
  • 市場規模と予測と動向分析、メーカー別、2018～2030年
  • 社内
  • アウトソーシング

第5章 合成小分子API市場：用途ビジネス分析

  • 用途市場シェア、2024年と2030年
  • 用途セグメントダッシュボード
  • 市場規模と予測と動向分析、用途別、2018～2030年
  • 心血管疾患
  • 腫瘍学
  • 中枢神経系と神経学
  • 整形外科
  • アウトソーシング
  • 内分泌学
  • 呼吸器科
  • 消化器内科
  • 腎臓学
  • 眼科
  • その他

第6章 合成小分子API市場：地域推定・動向分析、メーカーと用途

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Merck &Co., Inc.
    • AbbVie, Inc.
    • Bristol-Myers Squibb Company
    • Albemarle Corporation
    • Boehringer Ingelheim International GmbH
    • Cipla, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Aurobindo Pharma
    • Sun Pharmaceutical Industries Ltd.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global synthetic small molecule API market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 5 Global synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 6 North America synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 8 North America synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 9 U.S. synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 10 U.S. synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 11 Canada synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 12 Canada synthetic small molecule API market, by Application, 2018 - 2030 (USD Billion)
  • Table 13 Mexico synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 14 Mexico synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 15 Europe synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 17 Europe synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 18 UK synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 19 UK synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 20 Germany synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 21 Germany synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 22 France synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 23 France synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 24 Italy synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 25 Italy synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 26 Spain synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 27 Spain synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 28 Denmark synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 29 Denmark synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 30 Sweden synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 31 Sweden synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 32 Norway synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 33 Norway synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 37 Japan synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 38 Japan synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 39 China synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 40 China synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 41 India synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 42 India synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 43 Australia synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 44 Australia synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 45 South Korea synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 South Korea synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 47 Thailand synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 48 Thailand synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 49 Latin America synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 50 Latin America synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 51 Latin America synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 52 Brazil synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 53 Brazil synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 54 Argentina synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 55 Argentina synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 56 Middle East & Africa synthetic small molecule API market, by country, 2018 - 2030 (USD Billion)
  • Table 57 Middle East & Africa synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 58 Middle East & Africa synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 59 South Africa synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 60 South Africa synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 61 Saudi Arabia synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 63 UAE synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 64 UAE synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Kuwait synthetic small molecule API market, by manufacturer, 2018 - 2030 (USD Billion)
  • Table 66 Kuwait synthetic small molecule API market, by application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Synthetic small molecule API market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Manufacturer and application outlook (USD Billion)
  • Fig. 9 Competitive landscape
  • Fig. 10 Synthetic small molecule API market dynamics
  • Fig. 11 Synthetic small molecule API market: Porter's five forces analysis
  • Fig. 12 Synthetic small molecule API market: PESTLE analysis
  • Fig. 13 Synthetic small molecule API market: Manufacturer segment dashboard
  • Fig. 14 Synthetic small molecule API market: Manufacturer market share analysis, 2024 & 2030
  • Fig. 15 In-house market, 2018 - 2030 (USD Billion)
  • Fig. 16 Outsourced market, 2018 - 2030 (USD Billion)
  • Fig. 17 Synthetic small molecule API market: Application segment dashboard
  • Fig. 18 Synthetic small molecule API market: Application market share analysis, 2024 & 2030
  • Fig. 19 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
  • Fig. 20 Oncology market, 2018 - 2030 (USD Billion)
  • Fig. 21 CNS and neurology market, 2018 - 2030 (USD Billion)
  • Fig. 22 Orthopedic market, 2018 - 2030 (USD Billion)
  • Fig. 23 Endocrinology market, 2018 - 2030 (USD Billion)
  • Fig. 24 Pulmonology market, 2018 - 2030 (USD Billion)
  • Fig. 25 Gastroenterology market, 2018 - 2030 (USD Billion)
  • Fig. 26 Nephrology market, 2018 - 2030 (USD Billion)
  • Fig. 27 Ophthalmology market, 2018 - 2030 (USD Billion)
  • Fig. 28 Others market, 2018 - 2030 (USD Billion)
  • Fig. 29 Synthetic small molecule API market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 39 Europe synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 44 France country dynamics
  • Fig. 45 France synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 54 Norway country dynamics
  • Fig. 55 Norway synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 56 Asia Pacific synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 59 China country dynamics
  • Fig. 60 China synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 61 India country dynamics
  • Fig. 62 India synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 69 Latin America synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 74 MEA synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait synthetic small molecule API market, 2018 - 2030 (USD Billion)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework
目次
Product Code: GVR-4-68039-976-3

Synthetic Small Molecule API Market Growth & Trends:

The global synthetic small molecule API market size is estimated to reach USD 257.4 billion by 2030, registering a CAGR of 5.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the increasing demand for pharmaceuticals and new small molecule-based drugs globally. Moreover, small molecules API offers versatility between dosage forms and has an easier means of purification, which makes it more acceptable and increases the demand.

There is an increasing dominance of synthetic drugs in the pharmaceutical industry, which is expected to propel the requirement of raw materials such as small molecule APIs for production. Moreover, technological advancements related to the enhancement of existing products are expected to provide new opportunities for small molecule therapeutics. For instance, in March 2022, Evonik launched the new EUDRATECSoluFlow technology that enhances the solubility of oral small molecules.

The market is driven by positive government support for the production of APIs in various regions, particularly in Asia, where the majority of API manufacturers are dependent on the supply of API for the production of synthetic small molecule APIs. There has been an increasing focus on outsourcing activities for API production. For instance, in April 2020, for managing COVID-19, Wavelength Pharmaceuticals expanded the supply of key drug ingredients for certain pharmaceutical products needed to manage respiratory critical care patients and launched API CDMO services. Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth.

The investment in new and complex technologies is relatively low for Asian manufacturers as they are more focused on less complex molecules that can be produced in bulk. Thus, the investment in high-yielding, low-cost technologies is an alternative for manufacturers in other developed regions such as Europe and North America to avoid competitive pressure.

Key players operating in the market are focusing on collaboration for the production of potent API products. For instance, in August 2021, Almac Sciences signed an agreement with Pila Pharma for the production of the API XEN-D0501, a highly potent and selective small molecule TRPV1 antagonist. Moreover, CDMOs are constantly evolving by expanding their capacities to meet the heightened demand for synthetic drugs. For instance, in April 2022, AGC Inc. announced the expansion of its Spanish facility by 7500 m2 for synthetic pharmaceutical production, which is expected to enhance the demand for synthetic small molecule active pharmaceutical ingredients in the region.

Synthetic Small Molecule API Market Report Highlights:

  • The growth of the overall market is attributed to the increasing production of pharmaceuticals with the increased demand for raw material
  • The API market is witnessing a key shift with the rise in the preference for CDMOs for the production of synthetic small molecule active pharmaceutical ingredients in bulk
  • By manufacturer, the outsourced segment is expected to witness fastest CAGR over the forecast period, owing to a dependency of small and mid-sized companies on outsourcing for commercial production
  • By application, the cardiovascular diseases segment dominated the market in 2024 with a market share of 21.7%, owing to their chronic nature and high global prevalence.
  • North America dominated the market in 2024, due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Manufacturer
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Synthetic Small Molecule API Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Synthetic Small Molecule API Market: Manufacturer Business Analysis

  • 4.1. Manufacturer Market Share, 2024 & 2030
  • 4.2. Manufacturer Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Manufacturer, 2018 to 2030 (USD Billion)
  • 4.4. In-house
    • 4.4.1. In-house Market, 2018 - 2030 (USD Billion)
  • 4.5. Outsourced
    • 4.5.1. Outsourced Market, 2018 - 2030 (USD Billion)

Chapter 5. Synthetic Small Molecule API Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
  • 5.5. Oncology
    • 5.5.1. Oncology Market, 2018 - 2030 (USD Billion)
  • 5.6. CNS and Neurology
    • 5.6.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
  • 5.7. Orthopedic
    • 5.7.1. Orthopedic Market, 2018 - 2030 (USD Billion)
  • 5.8. Outsourced
    • 5.8.1. Outsourced Market, 2018 - 2030 (USD Billion)
  • 5.9. Endocrinology
    • 5.9.1. Endocrinology Market, 2018 - 2030 (USD Billion)
  • 5.10. Pulmonology
    • 5.10.1. Pulmonology Market, 2018 - 2030 (USD Billion)
  • 5.11. Gastroenterology
    • 5.11.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
  • 5.12. Nephrology
    • 5.12.1. Nephrology Market, 2018 - 2030 (USD Billion)
  • 5.13. Ophthalmology
    • 5.13.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
  • 5.14. Others
    • 5.14.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 6. Synthetic Small Molecule API Market: Regional Estimates & Trend Analysis Manufacturer and Application

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden Synthetic Small Molecule API Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Billion)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. Australia Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. South Korea Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Synthetic Small Molecule API Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Merck & Co., Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. AbbVie, Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Bristol-Myers Squibb Company
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Albemarle Corporation
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Boehringer Ingelheim International GmbH
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Cipla, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Dr. Reddy's Laboratories Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Aurobindo Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Sun Pharmaceutical Industries Ltd.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives